Literature DB >> 33902006

Effects of advanced glycation end products on neutrophil migration and aggregation in diabetic wounds.

Yutian Kang1, Chongliang Zheng1, Junna Ye2, Fei Song1, Xiqiao Wang1, Yingkai Liu1, Ming Tian1, Jiaoyun Dong1, Shuliang Lu1.   

Abstract

Increased accumulation of advanced glycation end products (AGEs) in diabetic skin is closely related to delayed wound healing. Studies have shown that the concentration of AGEs is elevated in the skin tissues and not subcutaneous tissues in refractory diabetic wounds, which suggests there may be a causal relationship between the two. In the present study, in vitro experiments revealed that AGEs activated neutrophils, and the migratory and adhesive functions of neutrophils decreased once AGE levels reached a certain threshold. Different levels of AGE expression differentially affected the function of neutrophils. Messenger RNA (mRNA) sequencing analysis combined with real-time polymerase chain reaction (PCR) showed that poliovirus receptor (PVR/CD155) and CTNND1, which play a role in migration- and adhesion-related signaling pathways, were decreased following AGE stimulation. Consequently, neutrophils cannot effectively stimulate the formation of the inflammatory belt needed to remove necrotic tissues and defend against foreign microorganisms within diabetic chronic wounds. In addition, this phenomenon may be related to the differential accumulation of AGEs in different layers of the skin.

Entities:  

Keywords:  AGEs; CTNND1; diabetes; neutrophil migration; wound repair

Year:  2021        PMID: 33902006     DOI: 10.18632/aging.202924

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  1 in total

1.  Research progress on the mechanism by which skin macrophage dysfunction mediates chronic inflammatory injury in diabetic skin.

Authors:  Jiali Huang; Shili Zhang; Xinyi Ding; Shuxian Li; Xiangrong Luo; Ying Cao; Fang Gao; Mengchen Zou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-24       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.